Accellix, a global leader in rapid, point-of-need cytometry solutions, is pleased to announce the appointment of Félix A. Montero-Julian, PhD, as Vice President of Scientific Affairs. Bringing more than 30 years of international experience in scientific affairs, analytical development, and regulatory science, Dr. Montero-Julian will support Accellix’s strategic vision and innovation roadmap.
Dr. Montero-Julian joins Accellix from bioMérieux, where he most recently served as Scientific Director of Pharmaceutical Quality Control. He also served as Director of Cytometry R&D at bioMérieux and Director of Cell Analysis at Beckman Coulter, bringing a wealth of experience in biopharmaceuticals, industrial microbiology, and clinical diagnostics.
“I am very excited to join Accellix during this period of dynamic growth and innovation for the company,” said Dr. Montero-Julian. “I have great confidence in the potential of the Accellix platform to transform quality control in cell and gene therapy manufacturing and blood characterization. I look forward to collaborating closely with this exceptional team to accelerate innovation and make a meaningful impact on our partners and the patients they serve.”
Also Read: Heather Wilberger Named VP, Chief Info & Digital Officer at NSF
Dr. Montero-Julian holds a PhD and MSc in Immunology from Aix-Marseille II University, France, and an Engineering degree in Industrial Biochemistry from the Universidad Autónoma Metropolitana, Mexico. He has also completed management training to specialize in business development, quality systems, and regulatory affairs. A respected thought leader in the development and regulatory acceptance of analytical methods for advanced therapies and biomanufacturing, he is the author of over 60 scientific publications.
“We are honored to welcome Félix to the Accellix leadership team,” said Greg Hamilton, CEO of Accellix. “His deep scientific knowledge and leadership experience in cytometry, regulatory science, and pharmaceutical quality control make him uniquely suited to shape our scientific strategy and partnerships as we seek to expand the impact of the Accellix platform.”
As Vice President of Scientific Affairs, Dr. Montero-Julian will lead Accellix’s scientific engagement strategy and foster cross-functional collaboration across R&D, regulatory, and commercial teams. He will also help advance the company’s mission to make rapid, automated cytometry accessible and reliable for blood collection centers and cell therapy manufacturers.
Source: Businesswire